VN December 2020

Vetnews | December 2020 7 and Prof Gerry Swan. It was first synthesised for wildlife in the early 1990s by Dr William Lance from Wildlife Pharmaceuticals Inc. in the USA and was later registered in South Africa by Wildlife Pharmaceuticals (Pty) Ltd. (Thianil 10 mg/ml, Wildlife Pharmaceuticals (Pty) Ltd.). While thiafentanil only has 63-75 % the potency of carfentanil, it is twice as potent as etorphine. Coupled with the fact that it is rapidly absorbed, this means that thiafentanil results in quicker inductions compared to etorphine. Its rapidmetabolism results in shorter duration of action (30-40 minutes) with quick recoveries following antagonism with naltrexone. It also has great synergistic effects when used in combination with etorphine, azaperone or alpha 2 -agonists. Like etorphine, thiafentanil causes hypertension in rhino and elephant and severe respiratory depression, particularly in white rhino. It is also not effective in equids. With the introduction of potent opioids in wildlife veterinary medicine, immobilisation and translocation of animals has become considerably easier.Treating injured free-ranging animals has abecome substantially simpler. Much research has gone into the combination of potent opioids with various sedatives and tranquilisers, marking a new era that is focused on single injection species-specific anaesthetic combinations. v Dr Joel Alves with a African forest elephant darted with thiafentanil Buffalo darted with opioids Leading Article For more information on etorphine (Captivon 98) and thiafentanil (Thianil), please contact Wildlife Pharmaceuticals (Pty) Ltd: vetsupplies@wildpharm.co.za A free webinar on the history of potent opioids in wildlife medicine is also available at: www.wildpharm.net

RkJQdWJsaXNoZXIy OTc5MDU=